Origin and genetic background of insulinomas

Endocrine Pathology

Volumn 10, Issue 4, 1999, Pages 283-290

  Rindi, Guido ^b   Candusso, M E ^c   Marchetti, A L ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Anatomia Patologica I   (Italy)

^c NONE

Author keywords

Endocrine cells; Genetics; Insulinoma; Pancreas

Indexed keywords

PROTEIN P53;

ARTICLE; CELL PROLIFERATION; ENDOCRINE TUMOR; GENE MUTATION; HUMAN; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033509830     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739770     Document Type: Article

References (66)

1. 1. Solcia E, Capella C, Klöppel G. Tumors of the pancreas. Armed Forces Institute of Pathology, Atlas of tumor pathology, 3rd Series, Fascicle 20, Washington DC, 1998.
2. 2. Davidson PM, Campbell IL, Oxbrow L, Hutson JM, Harrison LC. Pancreatic beta cell proliferation in rabbits demonstrated by bromodeoxyuridine labeling. Pancreas 4:594-600, 1989.
3. 3. Hultquist GT, Karlsson U, Hallner AC. The regenerative capacity of the pancreas in ductligated rats. Exp Pathol 17:44-52, 1979.
4. 4. Bonner-Weir S, Trent DF, Weir GC. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544-53, 1983.
5. 5. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. Diabetes 42:1715-1720, 1993.
6. 6. Korcakova L. Mitotic division and its significance for regeneration of granulated B-cells in the islets of Langerhans in alloxane-diabetic rats. Folia Morphol 19:24-30, 1971.
7. 7. Gu D and Sarvetnick N. Epithelial cell proliferation and islet neogenesis in INF-γ transgenic mice. Development 118:33-46, 1993.
8. 8. Higuchi Y, Herrera P-L, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli P. Expression of a tumor necrosis factor α-transgene in murine pancreatic β-cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731, 1992.
9. 9. Campbell IL, Hobbs MV, Dockter J, Oldstone MBA, Allison J. Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol 145:157-166, 1994.
10. 10. Pictet R, Rutter WJ. Development of the embryonic endocrine pancreas. In: D.F. Steiner and N. Frenkel eds. Handbook of Physiology, Section 7, Washington: American Physiological Society, 25-66, 1972.
11. 11. Rall LB, Pictet RL, Williams RH, Rutter WJ. Early differentiation of glucagon producing cells in embryonic pancreas: a possible developmental role for glucagon. Proc Natl Acad Sci USA 70:3478-3482, 1973.
12. 12. Upchurch BH, Aponte GW, Leiter AB. Expression of peptide YY in all four islet cell types in the deveoping mouse pancreas suggests a common peptide YY-producing progenitor. Development 120:245-252, 1994.
13. 13. Upchurch BH, Fung BF, Rindi G, Ronco A, Leiter AB. Peptide YY expression is an early event in colonie differentiation: evidence from normal and transgenic mice. Development 122:1157-1163, 1996.
14. 14. Brand SJ, Fuller PJ. Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 263:5341-5347, 1988.
15. 15. Wheeler MB, Nishitani J, Buchan AMJ, Kopin AS, Chey WY, Chang T, Leiter AB. Identification of a trascriptional enhancer important for enteroendocrine and pancreatic islet cell-specific expression of the secretin gene. Mol Cell Biol 12:3531-3539, 1992.
16. 16. Gu D, Lee M-S, Krahl T, Sarvetnick N. Transitional cells in the regenerating pancreas. Development 120:1873-1881, 1993.
17. 17. Mukai K, Greider MH, Grottin JC, Rosai J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 6: 387-99, 1982.
18. 18. Bordi C, De Vita O, Ferrari C, Altavilla G, Corallini A, Barbanti-Brodano G. Histologic, immunofluorescence and ultrastructural study of malignant islet-cell tumors of the pancreas induced in Hamsters by BK human Papovavirus. Am J Pathol 118:256-265, 1985.
19. 19. Rindi G, Bishop AE, Murphy D, Solcia E, Hogan B, Polak JM. Morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice. Virchow Archiv A 412: 255-266, 1988.
20. 20. Rindi G, Grant SGN, Yiangou Y, Gathei M, Bloom SR, Bautch V, Solcia E, Polak JM. Development of neuroendocrine tumours in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. Am J Pathol 136:1349-1363, 1990.
21. 21. Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V. Continuos, clonal, insulin-and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA 77:3519-3523, 1980.
22. 22. Madsen OD, Larsson LI, Rehfeld JF, Schwartz TW, Lernmark A, Labreqcque AD, Steiner DF. Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J. Cell Biol. 103:2025-2034, 1986.
23. 23. Lopez MJ, Upchurch BH, Rindi G, Leiter AB. Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. J Biol Chem 270:885-891, 1995.
24. 24. Efrat S, Teitelman G, Anwar M, Ruggiero D, Hanahan D. Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alfa cells. Neuron 1:605-613, 1988.
25. 25. Rindi G, Efrat S, Ghatei MA, Bloom SR, Solcia E, Polak JM. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides. Virchows Archiv A 419:115-129, 1991.
26. 26. Dombrowski F, Klingmüller D, Pfeifer U. Insulinomas derived from hyperplastic intraepatic islet transplant. Am J Pathol, 152:1025-1038, 1998.
27. 27. Corallini A, Altavilla G, Cecchetti MG, Fabris G, Grossi MP, Balboni PG et al. Ependymomas, malignant tumors of pancreatic islets and osteosarcomas induced in hamsters by BK virus, a human papovavirus. J Natl Cancer Inst 61:875-883, 1978.
28. 28. Caputo A, Corallini A, Grossi MP, Carra' I., Balboni PG, Negrini M et al. Episomal DNA of a BK virus variant in a human insulinoma. J Med Virol 12:37-49, 1982.
29. 29. Pater MM, Pater A, Fiori M, Slota J, di Mayorca G. BK virus sequences in human tumors and normal tissues and cell lines. In: Essex M, Todaro G, Zur Hausen H, editors. Viruses in Naturally Occurring Cancers. Cold Spring Harbor Lab: Cold Spring Harbor 329-341, 1980.
30. 30. Griffiths DFR, Williams GT, Williams ED. Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Quart J Med 245:769-782, 1987.
31. 31. Probst A, Lotz M, Heitz P. Von Hippel-Lindau's disease, syringomyelia and multiple endocrine tumors: a complex neuroendocrinopathy. Virchows Arch A Anat Path Istol 378:265-272, 1978.
32. 32. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt M, Stackhouse T, Kuzmin I, Modi W, Geil L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993.
33. 33. Lott ST, Curley SA, Killary AM. Loss of heterozygosity at 3p13-3p21 in pancreatic islet cell tumors associated with von Hippel Lindau disease. Proc Am Ass Cancer Res 35:572, 1994.
34. 34. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 100:404-410, 1997.
35. 35. Larsson K, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87, 1988.
36. 36. Chandrasekharrappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal AK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene of Multiple Endocrine Neoplasia-Type 1. Science 276:404-407, 1997.
37. 37. Bale AE, Norton JA, Wong EL, Fryburg JS, Maton PN, Oldfield EH et al. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res 51:11 54-1157, 1991.
38. 38. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa S, Manickam P, Guru SC et al. Allelic deletions on chromosome 11q31 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238-2243, 1997.
39. 39. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56:5272-5278, 1996.
40. 40. Teh BT, Hayward NK, Wilkinson S, Woods GM, Cameron D, Sheperd JJ. Clonal loss of INT-2 alleles in sporadic and familial pancreatic endocrine tumours. Br J Cancer 62:253-254, 1990.
41. 41. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA. A microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter in size. Am J Pathol 146:620-625, 1995.
42. 42. Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C, Scarpa A. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumor suppressor gene on chromosome 17p. J Pathol 186:41-50, 1998.
43. 43. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park W-S, Agarwal SK et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686, 1997.
44. 44. Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoyo M, Arima R, Kameya T, Kakudo K. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest 78:471-475, 1998.
45. 45. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr, Sawicki M. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Cancer Res 58:4417-4420, 1998.
46. 46. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250-1233-1238, 1990.
47. 47. Yokota J, Sugimura T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J 7:920-925, 1993.
48. 48. Rindi G Transgenic models of endocrine tumors. In Polak JM (Ed) Diagnostic Histopathology of Neuroendocrine Tumors, Churchill-Livingstone, London, pp. 67-89, 1993.
49. 49. Ludlow JW. Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRb and p53. FASEB J 7:866-871, 1993.
50. 50. Messing A, Chen HY, Palmiter RD, Brinster RL. Peripheral neuropaties, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature 316:461-463, 1985.
51. 51. Reynolds RK, Hoekzema GS, Vogel J, Hinrichs SH, Jay G. Multiple endocrine neoplasia induced by the promiscous expression of a viral oncogene. Proc Natl Acad Sci USA 85:3135-3139, 1988.
52. 52. Harvey M, Vogel HM, Lee EYHP, Bradley A, Donehower LA. Mice deficient in both p53 and Rb develop tumours primarily of endocrine origin Cancer Res 55:1146-1151, 1995.
53. 53. Chung DC, Smith AP, Louis DN, Graeme-Cook F, Warshaw AL, Arnold A. Analysis of the retinoblastoma tumor suppressor gene in pancreatic endocrine tumours. Clin Endocrinol 47:523-528, 1997.
54. 54. Pearce SH, Trump D, Wooding C, Sheppard MN, Clayton RN, Thakker RV. Loss of heterzygosity studies at the retinoblastoma and breast cancer suceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours. Clin Endocrinol 45:195-200, 1996.
55. 55. Iwamura Y, Futagawa T, Kaneko M, Nakagawa K, Kawai K, Yamashita K, Nakamura T, Hayashi H. Co-deletions of the retinoblastoma gene and Wilms' tumor gene and rearrangement of the Krev-1 gene in a human insulinoma. Jpn J Clin Oncol 22:6-9, 1992.
56. 56. Bartz C, Ziske C, Wiedenmann B, Moelling K p53 tumor suppressor gene expression in pancreatic neuroendocrine tumor cells. Gut 38:403-409, 1996.
57. 57. Lam KY, Lo CY. Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients. Am J Gastroenterol 93:1323-1325, 1998.
58. 58. Lohman DR, Funk A, Niedermeyer HP, Häupel S, Höfler H. Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch B 64:293-296, 1993.
59. 59. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556-1560, 1994.
60. 60. Tomita T. p53 and proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids. Pathology 29:147-153, 1997.
61. 61. Roncalli M, Coggi G. Oncogenes and neuroendocrine tumours. In: JM Polak, ed. Diagnostic histopathology of neuroendocrine tumours. Churchill Livingstone, London, UK 41-66, 1993.
62. 62. Chesa PG, Rettig WG, Melamed MR, Old LJ, Niman NL. Expression of p21 ras in normal and malignant human tissues: lack of association with proliferation and malignancy. Proc Nad Acad Sci USA 84:3234-3238, 1987.
63. 63. Roncalli M, Springall DS, Varndell I, Gaitonde VV, Hamid Q, Ibrahim NBN, Grimelius L, Wilander E, Polak JM, Coggi C. Oncoprotein immunoreacdvity in human endocrine tumours. J Pathol 163:117-127, 1991.
64. 64. Höfler H, Ruhri C, Putz B, Wirsnberger G, Hauser H. Oncogene expression in endocrine pancreatic tumours. Virchows Arch B Cell Path 55:355-361, 1988.
65. 65. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Beliocza M, Kruslin B, Cabrijan T. Multiple genetic alterations in malignant metastatic insulinomas. J Pathol 177:395-400, 1995.
66. 66. Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrock P, Gluckman JL, Pavelic ZP. Molecular genetics of malignant insulinoma. Anticancer Res 16:1707-1717, 1996.